October 14, 2022
Feature Articles
31
10
Pursuing new tools and capabilities in sample logistics, storage, and data analysis.
October 14, 2022
Feature Articles
31
10
The benefits of working with an institutional biosafety committee in CGT research.
October 14, 2022
Feature Articles
31
10
Integrated approaches can help enhance recruitment plans.
October 14, 2022
Feature Articles
31
10
Approaches sponsors, CROs, and investigators can take from the DMD experience.
October 14, 2022
Feature Articles
31
10
As activity in this space grows, so do the hurdles in moving these products forward.
October 14, 2022
News
31
10
Chamber of Commerce for Greater Philadelphia ranks city No. 2 overall for cell CGT hubs.
October 14, 2022
Data Collection
31
10
Survey results emphasize need for flexibility in strategies.
October 14, 2022
View from Brussels
31
10
New EU clinical trial regulation places heavy importance on patient-submitted documents.
October 14, 2022
From the Editor
31
10
Cell and gene therapy space set to advance amid recent therapeutic innovation.
October 14, 2022
Issue PDF
31
10
Click the title above for a link to open the Applied Clinical Trials October 2022 issue in an interactive PDF format.
September 22, 2022
Q&A
31
10
Barbara Lopez Kunz, president, and global chief executive at DIA, discusses key themes on the current state of the clinical trials industry and its future.
September 20, 2022
View from Washington
31
10
Agency officials express associated concerns around clinical trial data reliability and quality.
September 16, 2022
A Closing Thought
31
10
Accelerating trends in clinical data are forcing changes in strategy.